3060 A Phase II study of oral vinorelbine monotherapy in patients with advanced EGFR-positive Non-Small-Cell Lung Cancer (NSCLC) after failure of EGFR-TKI in first line (NAVoTRIAL 2): Preliminary efficacy and safety results

Final results of a phase II study of oral vinorelbine (NVBo) monotherapy in patients (pts) with advanced EGFR-positive non-small-cell lung cancer (NSCLC) after failure of EGFR-TKI in first line (NAVoTRIAL 2).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e20546 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e20546-e20546

Author(s):

Eng-Huat Tan ◽

Giuseppe Luigi Banna ◽

Rodryg Ramlau ◽

Giovanni Luca Ceresoli ◽

Andrea Camerini ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

Final results of a phase II study of oral vinorelbine (NVBo) monotherapy in patients (pts) with advanced EGFR-positive non-small-cell lung cancer (NSCLC) after failure of EGFR-TKI in first line (NAVoTRIAL 2)

Annals of Oncology ◽

10.1093/annonc/mdw383.84 ◽

2016 ◽

Vol 27 ◽

pp. vi446

Author(s):

E.-H. Tan ◽

G. Banna ◽

R. Ramlau ◽

G. Ceresoli ◽

A. Camerini ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01)

Clinical Lung Cancer ◽

10.1016/j.cllc.2014.04.007 ◽

2014 ◽

Vol 15 (4) ◽

pp. 258-265 ◽

Cited By ~ 8

Author(s):

Jaafar Bennouna ◽

Libor Havel ◽

Maciej Krzakowski ◽

Jens Kollmeier ◽

Radj Gervais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Line Chemotherapy

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

British Journal of Cancer ◽

10.1038/bjc.2012.555 ◽

2013 ◽

Vol 108 (2) ◽

pp. 265-270 ◽

Cited By ~ 22

Author(s):

A Atmaca ◽

S-E Al-Batran ◽

D Werner ◽

C Pauligk ◽

T Güner ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Multicentre Phase ◽

First Line Therapy ◽

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Cited By ~ 4

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3092-9 ◽

2016 ◽

Vol 78 (2) ◽

pp. 383-388 ◽

Cited By ~ 3

Author(s):

Yusuke Okuma ◽

Yukio Hosomi ◽

Satoshi Takahashi ◽

Yoshiro Nakahara ◽

Kageaki Watanabe ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Randomised Phase II Study of Axitinib or Bevacizumab Combined with Paclitaxel/Carboplatin (PAC/CARB) as First-Line Therapy for Patients (PTS) with Advanced Non–Small Cell Lung Cancer (NSCLC)

Annals of Oncology ◽

10.1016/s0923-7534(20)33840-0 ◽

2012 ◽

Vol 23 ◽

pp. ix408

Author(s):

C. Twelves ◽

E. Chmielowska ◽

L. Havel ◽

S. Popat ◽

A. Swieboda-Sadlej ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)30568-8 ◽

2015 ◽

Vol 51 ◽

pp. S196

Author(s):

M. Tamiya ◽

A. Tamiya ◽

H. Kaneda ◽

K. Nakagawa ◽

K. Goto ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Line Chemotherapy

Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-018-3596-6 ◽

2018 ◽

Vol 82 (1) ◽

pp. 119-127

Author(s):

Hisao Imai ◽

◽

Hiroyuki Minemura ◽

Tomohide Sugiyama ◽

Yutaka Yamada ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Egfr Mutations ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Tki Treatment ◽

Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2006.61.2.143 ◽

2006 ◽

Vol 61 (2) ◽

pp. 143

Author(s):

Ki Eun Hwang ◽

So Young Kim ◽

Jong Hoon Jung ◽

Seong Hoon Park ◽

Jung Hyun Park ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽